Cargando…

The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus

INTRODUCTION: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) present with a complex phenotype and are associated with high mortality and multi-organ involvement. We sought to define the transcriptional landscape and molecular endotypes of AAVs and compare it to systemic l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banos, Aggelos, Thomas, Konstantinos, Garantziotis, Panagiotis, Filia, Anastasia, Malissovas, Nikolaos, Pieta, Antigone, Nikolakis, Dimitrios, Panagiotopoulos, Alexandros G., Chalkia, Aglaia, Petras, Dimitrios, Bertsias, George, Boumpas, Dimitrios T., Vassilopoulos, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083368/ https://www.ncbi.nlm.nih.gov/pubmed/37051253 http://dx.doi.org/10.3389/fimmu.2023.1072598

Ejemplares similares

Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies
por: Banos, Aggelos, et al.
Publicado: (2020)

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
por: Garantziotis, Panagiotis, et al.
Publicado: (2022)

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study
por: Chalkia, Aglaia, et al.
Publicado: (2020)

Development of an ANCA-Associated Vasculitides Patient Registry in Greece
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients
por: Thomas, Konstantinos, et al.
Publicado: (2021)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
por: Nikolakis, Dimitrios, et al.
Publicado: (2023)

Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus
por: Grigoriou, Maria, et al.
Publicado: (2020)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
por: Nikolopoulos, Dionysis, et al.
Publicado: (2022)

TGF-β1/Smad Signalling in Proliferative Glomerulonephritis Associated with Autoimmune Diseases
por: Chalkia, Aglaia, et al.
Publicado: (2022)

Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis
por: Frangou, Eleni, et al.
Publicado: (2022)

Patrolling human SLE haematopoietic progenitors demonstrate enhanced extramedullary colonisation; implications for peripheral tissue injury
por: Kokkinopoulos, Ioannis, et al.
Publicado: (2021)

A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies
por: Sentis, George, et al.
Publicado: (2023)

Pulmonary-Renal Syndrome During COVID-19 Pandemic Revealed a Rare Case of Anti-GBM Disease
por: Chalkia, Aglaia, et al.
Publicado: (2023)

ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus
por: Manolakou, Theodora, et al.
Publicado: (2022)

Combined – whole blood and skin fibroblasts- transcriptomic analysis in Psoriatic Arthritis reveals molecular signatures of activity, resistance and early response to treatment
por: Grivas, Alexandros, et al.
Publicado: (2022)

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
por: Nikolopoulos, Dionysis S, et al.
Publicado: (2020)

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
por: Stergioti, Eirini Maria, et al.
Publicado: (2022)

Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus
por: Nikolopoulos, Dionysis, et al.
Publicado: (2023)

Daratumumab for the treatment of refractory ANCA-associated vasculitis
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Advances in Systemic Lupus Erythematosus (SLE): A case for optimism
por: Fanouriakis, Antonis, et al.
Publicado: (2017)

2018 Position Paper on Biosimilars of the Greek Rheumatology Society and Professional Association of Greek Rheumatologists
por: Patrikos, Dimos, et al.
Publicado: (2019)

Rheumatoid Arthritis-associated Interstitial Lung Disease in Greece: A Multicentre Epidemiological and Clinical Study
por: Karageorgas, Theofanis, et al.
Publicado: (2018)

Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus
por: Nakou, Magdalene, et al.
Publicado: (2010)

Correction: Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus
por: Nakou, Magdalene, et al.
Publicado: (2013)

Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus
por: Ntasis, Vasilis F., et al.
Publicado: (2020)

Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management
por: Nikolopoulos, Dionysis, et al.
Publicado: (2019)

Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
por: Sidiropoulos, Prodromos, et al.
Publicado: (2019)

Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis
por: Goel, Ruchika, et al.
Publicado: (2021)

Study of the natural course and specific immunity after herpes zoster in patients with rheumatoid arthritis receiving biologic DMARDs
por: Thomas, Konstantinos, et al.
Publicado: (2017)

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study
por: Pappa, Maria, et al.
Publicado: (2022)

Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2020)

Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA
por: Sowa, Mandy, et al.
Publicado: (2014)

Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2020)

Correction: Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA
por: Sowa, Mandy, et al.
Publicado: (2015)

Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study
por: Karampeli, Maria, et al.
Publicado: (2020)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)
por: Frangou, Eleni, et al.
Publicado: (2019)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
por: Adamichou, Christina, et al.
Publicado: (2021)

Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
por: Alunno, Alessia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vrc6nqiulqi03b7tj9kf9upml8